title: Endovascular treatment of an aneurysm of the descending thoracic aorta in a heart transplant recipient: long-term result.
abstract: Heart-transplanted patients have a known higher incidence of aortic aneurysms. However, there is paucity of information regarding thoracic localisation in this clinical setting and of the endovascular option in such patients with chronically high level of immunosuppressive agents. We describe long-term follow-up of a 72-year-old man who developed an aneurysm of the descending part of the thoracic aorta 10 years after an orthotopic cardiac transplantation. Because of comorbid medical conditions, classical open-chest procedure could not be performed. An alternative treatment by endovascular repair was applied successfully and allowed a perfect exclusion of the aneurysm. Chronically high level of immunosuppressive agents seems not to be a contraindication to the endovascular option. Consequently, extended cardiovascular screening of heart-transplanted patients is desirable to facilitate early detection and elective endovascular repair.
authors.affiliation: Department of Cardio-Vascular Surgery, Bordeaux Heart University Hospital, Avenue de Magellan, F. 33 604 Bordeaux-Pessac, France. louis.labrousse@chu-bordeaux.fr
authors.forename: Louis
authors.initials: L
authors.lastname: Labrousse
authors.forename: Michel
authors.initials: M
authors.lastname: Montaudon
authors.forename: Marc-Alain
authors.initials: MA
authors.lastname: Billes
authors.forename: Claude
authors.initials: C
authors.lastname: Deville
mesh_terms: D000368:Aged; D017545:Aortic Aneurysm, Thoracic / Q000209:etiology / Q000601:surgery; D001019:Aortic Rupture / Q000209:etiology / Q000601:surgery*; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D015607:Stents; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents